Partnervest Advisory Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$442K Buy
+6,989
New +$485K 0.14% 123
2020
Q2
Sell
-5,905
Closed -$441K 237
2020
Q1
$441K Buy
+5,905
New +$408K 0.2% 94
2017
Q1
Sell
-3,607
Closed -$258K 203
2016
Q4
$258K Sell
3,607
-1,614
-31% -$120K 0.12% 164
2016
Q3
$413K Buy
5,221
+1,031
+25% +$83.8K 0.2% 114
2016
Q2
$350K Buy
4,190
+433
+12% +$38.4K 0.17% 124
2016
Q1
$345K Buy
3,757
+1,739
+86% +$157K 0.18% 120
2015
Q4
$204K Buy
+2,018
New +$210K 0.11% 154
2015
Q3
Sell
-1,877
Closed -$220K 173
2015
Q2
$220K Buy
+1,877
New +$205K 0.11% 166
2014
Q3
Sell
-1,401
Closed -$116K 396
2014
Q2
$116K Sell
1,401
-1,739
-55% -$135K 0.05% 224
2014
Q1
$221K Buy
3,140
+2,591
+472% +$203K 0.1% 137
2013
Q4
$41K Buy
+549
New +$38.2K 0.02% 339

Other funds holding GILD

Partnervest Advisory Services's GILD Position: Q3 2020 in Review

Partnervest Advisory Services opened a new position in Gilead Sciences (GILD) in Q3 2020: 6,989 shares worth $442K. The stake represents 0.14% of the portfolio and ranks #123 among its holdings. This is a return to the name: Partnervest Advisory Services previously reported a position in GILD as recently as Q1 2020.

Partnervest Advisory Services first reported a position in GILD in Q4 2013 and has held it in 11 quarters since. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Partnervest Advisory Services held 6,989 shares of Gilead Sciences worth $442K as of Q3 2020.
  • Gilead Sciences was a new Partnervest Advisory Services position in Q3 2020.
  • Gilead Sciences made up 0.14% of Partnervest Advisory Services's portfolio in Q3 2020, its #123 holding.
  • Partnervest Advisory Services first reported a position in Gilead Sciences in Q4 2013 and has held it in 11 quarters since.
  • 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Partnervest Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.